Evaluation of the Role of Brain Natriuretic Peptide in Acute Coronary Syndrome .

Launched by ASSIUT UNIVERSITY · Dec 11, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on studying a substance in the blood called Brain Natriuretic Peptide (BNP) and how it can help doctors understand and manage patients with Acute Coronary Syndrome (ACS), a serious condition that affects the heart. The researchers want to see if measuring BNP can help identify the severity of the condition and predict potential complications during hospital stays.

To participate in the trial, you need to be diagnosed with Acute Coronary Syndrome. However, certain patients are excluded, such as those who have had a previous heart attack, have significant heart function issues, or suffer from other serious medical conditions like liver or kidney diseases. If you qualify and choose to participate, you can expect to provide blood samples for BNP testing and be monitored closely during your hospital stay. This study aims to improve how doctors assess and treat patients with heart issues, potentially leading to better outcomes for those affected.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with acute coronary syndrome.
• Exclusion Criteria:
• • Patients with previous MI
• • Eection fraction (EF) less than 30%
• • Patients having cardiomyopathy
• • Patients having renal, liver, malignant, infectious, or inflammatory diseases .